| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $247.0K | $1.0M | $764.0K |
| YoY Revenue Growth % | -76.3% | +36.3% | — |
| Gross Profit | -$2.9M | -$486.0K | — |
| Gross Margin % | -50.0% | -46.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$53.1M | -$10.5M | -$12.2M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$55.6M | -$11.0M | -$11.8M |
| EBITDA (Normalized) | -$53.1M | -$10.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$13.8M | -$9.9M | -$12.2M |
| Capital Expenditures (CapEx) | $93.0K | $67.0K | — |
| Free Cash Flow (FCF) | -$13.9M | -$10.0M | -$12.2M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $27.0M | $7.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $119.2M | $6.7M | — |